Quantitative assessment of neuroleptic-induced extrapyramidal symptoms: clinical and nonclinical approaches

Clin Neuropharmacol. 1983;6 Suppl 1:S35-51. doi: 10.1097/00002826-198300061-00006.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Aged
  • Antipsychotic Agents / adverse effects*
  • Basal Ganglia Diseases / chemically induced*
  • Basal Ganglia Diseases / physiopathology
  • Blinking / drug effects
  • Dyskinesia, Drug-Induced / physiopathology
  • Electromyography
  • Humans
  • Huntington Disease / physiopathology
  • Middle Aged
  • Smoking
  • Tremor / physiopathology

Substances

  • Antipsychotic Agents